Symansis

Symansis was founded by a group of leading cancer research scientists from the UK, USA and New Zealand. The company is situated in modern facilities, with GMP manufacturing, in the South Island of New Zealand.

Symansis products are of particular use in drug discovery in the analysis of the effects of potential drug compounds on the activation of intra-cellular kinases. Symansis also supply human cell expressed proteins complete with all the glycosylation moieties ensuring full physiological function. These proteins are of interest in the fields of inflammation, cardiovascular disease, obesity and cancer.

If you are having difficulty downloading product data or require further information, please contact us.